Procept BioRobotics Corp (NASDAQ: PRCT) kicked off on Tuesday, down -1.18% from the previous trading day, before settling in for the closing price of $53.43. Over the past 52 weeks, PRCT has traded in a range of $47.04-$103.81.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 127.16%. While this was happening, its average annual earnings per share was recorded 13.69%. With a float of $51.88 million, this company’s outstanding shares have now reached $54.72 million.
Let’s determine the extent of company efficiency that accounts for 756 employees. In terms of profitability, gross margin is 60.5%, operating margin of -43.04%, and the pretax margin is -40.72%.
Procept BioRobotics Corp (PRCT) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Procept BioRobotics Corp is 5.37%, while institutional ownership is 92.22%. The most recent insider transaction that took place on Mar 18 ’25, was worth 312,404. In this transaction President, CEO of this company sold 5,475 shares at a rate of $57.06, taking the stock ownership to the 173,070 shares. Before that another transaction happened on Mar 18 ’25, when Company’s EVP, CFO sold 733 for $57.06, making the entire transaction worth $41,825. This insider now owns 107,991 shares in total.
Procept BioRobotics Corp (PRCT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.95% during the next five years compared to -12.56% drop over the previous five years of trading.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
Take a look at Procept BioRobotics Corp’s (PRCT) current performance indicators. Last quarter, stock had a quick ratio of 8.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.76, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -0.96 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Looking closely at Procept BioRobotics Corp (NASDAQ: PRCT), its last 5-days average volume was 1.09 million, which is a jump from its year-to-date volume of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 75.83%. Additionally, its Average True Range was 3.36.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 10.70%, which indicates a significant decrease from 51.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.51% in the past 14 days, which was higher than the 53.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $59.51, while its 200-day Moving Average is $73.60. However, in the short run, Procept BioRobotics Corp’s stock first resistance to watch stands at $54.35. Second resistance stands at $55.90. The third major resistance level sits at $57.12. If the price goes on to break the first support level at $51.58, it is likely to go to the next support level at $50.36. Should the price break the second support level, the third support level stands at $48.81.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
The company with the Market Capitalisation of 2.89 billion has total of 54,819K Shares Outstanding. Its annual sales at the moment are 224,500 K in contrast with the sum of -91,410 K annual income. Company’s last quarter sales were recorded 68,240 K and last quarter income was -18,860 K.
